Truist Financial Increases Chemours (NYSE:CC) Price Target to $21.00

Key Points

• Truist Financial raised Chemours' price target from $18.00 to $21.00, indicating a potential upside of 21.86% from its previous close.
• The company's stock has received a mix of ratings from analysts, with five analysts rating it as a Buy and four as Hold, leading to a consensus rating of "Moderate Buy".
• Chemours reported $0.58 earnings per share, exceeding estimates, with revenue for the quarter reaching $1.62 billion, a 5.0% increase year-over-year.

Chemours (NYSE:CC - Free Report) had its target price increased by Truist Financial from $18.00 to $21.00 in a research note released on Tuesday,Benzinga reports. Truist Financial currently has a buy rating on the specialty chemicals company's stock.

A number of other brokerages have also recently weighed in on CC. Wall Street Zen cut Chemours from a "hold" rating to a "sell" rating in a research note on Wednesday, May 21st. Barclays dropped their target price on Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 28th. Royal Bank Of Canada boosted their target price on Chemours from $14.00 to $15.00 and gave the stock an "outperform" rating in a research note on Thursday, July 3rd. Zacks Research upgraded Chemours from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 27th. Finally, Mizuho boosted their target price on Chemours from $13.00 to $16.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 15th. Five research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Chemours has an average rating of "Moderate Buy" and a consensus price target of $17.25.

Chemours Trading Down 3.0%

Shares of CC stock traded down $0.53 on Tuesday, reaching $17.00. 3,911,035 shares of the company's stock were exchanged, compared to its average volume of 2,933,894. Chemours has a 52 week low of $9.13 and a 52 week high of $22.38. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16. The stock has a market capitalization of $2.54 billion, a PE ratio of -6.07 and a beta of 1.61. The company's fifty day simple moving average is $14.52 and its 200 day simple moving average is $12.86.

Chemours (NYSE:CC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.12. The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.57 billion. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.Chemours's revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.38 EPS. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts forecast that Chemours will post 2.03 EPS for the current year.

Chemours Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 15th were issued a $0.0875 dividend. The ex-dividend date was Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a yield of 2.1%. Chemours's dividend payout ratio (DPR) is -12.50%.

Insider Transactions at Chemours

In related news, CEO Denise Dignam bought 4,068 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The stock was purchased at an average cost of $12.06 per share, for a total transaction of $49,060.08. Following the completion of the acquisition, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. This trade represents a 2.17% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.47% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC purchased a new position in Chemours in the first quarter valued at $822,000. Principal Financial Group Inc. boosted its position in shares of Chemours by 116.3% during the 1st quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company's stock worth $10,041,000 after acquiring an additional 399,097 shares in the last quarter. Millennium Management LLC boosted its position in shares of Chemours by 60.4% during the 1st quarter. Millennium Management LLC now owns 4,022,782 shares of the specialty chemicals company's stock worth $54,428,000 after acquiring an additional 1,515,520 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Chemours by 22.4% during the 1st quarter. Janney Montgomery Scott LLC now owns 31,886 shares of the specialty chemicals company's stock worth $431,000 after acquiring an additional 5,843 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Chemours by 1,115.2% during the 1st quarter. GAMMA Investing LLC now owns 18,617 shares of the specialty chemicals company's stock worth $252,000 after acquiring an additional 17,085 shares in the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.